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Lung cancer mortality and tobacco smoking in Poland – will we observe
further changes in mortality in light of recent smoking patterns?
Jerzy E. Tyczyƒski
I n t r o d u c t i o n.  Lung cancer continues to be a major oncological problem in Poland due to both the large number of cases
and poor prognoses of patients. In 1971 it had overtaken stomach cancer as the most frequent neoplasm in Polish men, while
in women its’ mortality is second only to that from breast cancer. Tobacco smoking is well established as the main cause of lung
cancer. There have been significant changes in tobacco consumption and prevalence in Poland during the last three decades.
These changes are having, and will continue to have, a major impact on the incidence of lung cancer in the Polish population.
M e t h o d s.  Joinpoint regression was used to derive estimated annual percentage change (EAPC) of lung cancer mortality and
to detect points in time where abrupt linear changes in the trends occur. The age-period-cohort statistical model (APC)
was used to estimate the secular and generational components of the trends.
Re s u l t s.  Results derived from the APC model indicate a plateau in mortality in men starting in the late1980s. Women born
after 1940 experienced a significant increase of lung cancer risk. It is likely that mortality from lung cancer in Poland will
continue to rise in women in the next 2-3 decades. It is more difficult to predict future changes in lung cancer mortality in Polish
men, although a subsequent decline might be anticipated given previous observations in other countries, at the equivalent stage
of the epidemic.
C o n c l u s i o n s.  There are various activities aimed at prevention and early detection of lung cancer, such as screening
trials, chemoprevention trials focused on prevention of lung cancer in high-risk groups, as well as studies on the genetic
predisposition to smoking and nicotine addiction. However, none of these activities have, as yet, proven to be effective at
a population level. Undoubtedly, the first choice strategy to reduce mortality from lung cancer in Poland should be the
reduction of the prevalence of smoking in men and women, and to target the rising number of tobacco smokers in the
young.
UmieralnoÊç na nowotwory z∏oÊliwe p∏uca i palenie tytoniu w Polsce
– czy w zwiàzku ze zmianami w cz´stoÊci palenia b´dziemy obserwowaç w przysz∏oÊci zmiany w umieralnoÊci?
W p r o w a d z e n i e.  Rak p∏uca pozostaje jednym z g∏ównych problemów onkologicznych w Polsce, tak ze wzgl´du na du˝à
liczb´ zachorowaƒ, jak i z∏e rokowania lecznicze. Jest to, od 1971 roku, najcz´Êciej notowany nowotwór u m´˝czyzn w Polsce,
i drugi (po raku piersi) nowotwór u kobiet. Palenie tytoniu jest g∏ównym czynnikiem ryzyka raka p∏uca. W Polsce, w ciàgu
ostatnich dziesi´cioleci dosz∏o do istotnych zmian w cz´stoÊci palenia tytoniu. Zmiany te majà i b´dà mia∏y w przysz∏oÊci
decydujàcy wp∏yw na zachorowalnoÊç na raka p∏uca w polskiej populacji.
M e t o d y.  Do okreÊlenia tempa zmian umieralnoÊci w czasie oraz okreÊlenia lat, w których nast´powa∏y istotne statystycznie
zmiany trendu, u˝yto „joinpoint regression” (JR). Dla okreÊlenia wp∏ywu okresów czasu i generacji urodzeniowych na
umieralnoÊç, u˝yto modeli „age-period-cohort” (APC).
W y n i k i.  Analiza APC oraz JR wskazuje na zahamowanie wzrostu umieralnoÊci u m´˝czyzn od koƒca lat 80. Kobiety
urodzone po 1940 roku majà istotnie podwy˝szone ryzyko raka p∏uca. Jest prawdopodobne, ˝e umieralnoÊç u kobiet b´dzie
wzrastaç przez nast´pne 2-3 dekady. Trudniej jest przewidzieç przysz∏e zmiany umieralnoÊci u m´˝czyzn, jakkolwiek, na
podstawie wczeÊniejszych obserwacji z innych krajów, znajdujàcych si´ na podobnym stopniu rozwoju epidemii palenia
tytoniu, mo˝na prognozowaç obni˝anie si´ poziomu umieralnoÊci w najbli˝szych latach.
W n i o s k i.  Istnieje wiele mo˝liwych dzia∏aƒ ukierunkowanych na zapobieganie i wczesne wykrywanie raka p∏uca. Sà to m.in.
programy skryningowe, chemoprewencja w grupach wysokiego ryzyka, jak równie˝ badania nad genetycznymi predyspozycjami
do palenia tytoniu i uzale˝nienia od nikotyny. Jednak˝e, ˝adne z tych dzia∏aƒ, jak dotychczas, nie sà skuteczne w skali
populacji, w obni˝aniu zachorowalnoÊci i umieralnoÊci na raka p∏uca. Dlatego te˝, podstawowà strategià obni˝ania
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Introduction
Lung cancer is the most common cancer in men
worldwide and one of the most common cancers in
women. In men, the highest incidence rates are observed
in Europe (especially Eastern Europe) and North
America. In women high incidence rates are also found in
North America and in Europe, particularly Northern and
Western Europe [1].
There were approximately 375,000 incident cases of
lung cancer in Europe in the year 2000 – (303,000 in men
and 72,000 in women). The number of lung cancer deaths
in Europe was about 347,000 (280,000 in men and 67,000
in women) [2]. In men, both incidence and mortality are
considerably higher in Eastern Europe than in other parts
of the continent, while in women, the highest incidence
and mortality rates are found in Northern Europe, where
they are about two times higher than in other European
areas [2, 3]. Lung cancer had overtaken stomach cancer in
1971 as the most frequent neoplasm in Polish men. In
women lung cancer is now the second most common
neoplasm after breast cancer [4].
Although there are several putative factors
influencing risk of developing lung cancer, tobacco
smoking is well established as the main causal agent [5-9].
This paper aims to describe the changes in lung cancer
mortality in Poland in relation to previous and current
trends in tobacco smoking in the Polish population.
Special emphasis is placed on the evolution of lung cancer
mortality according to period and birth cohort effects.
Material and methods
Data on deaths from malignant neoplasms of the trachea,
bronchus and lung were extracted from the World Health
Organisation (WHO) Mortality Databank, by five-year age
group and sex, using the code 162 according to the ICD-9
revision. Data were available for a 37-year period from 1963 to
1999. Corresponding population data, by age, sex and year, were
also extracted.
To evaluate changes in time trends in men and women,
age-standardised mortality rates for the period 1965-1999 were
calculated for all ages combined and truncated rates for the age
groups 20-34, 35-44, 45-54, 55-64, 65-74, and 75 and over, by
sex, using the weights of the World Standard Population [10].
A Joinpoint regression was then fitted to calculate the estimated
annual percentage change (EAPC) of each trend so as to detect
points in time where significant (abrupt linear) changes occur
[11, 12]. For each EAPC the corresponding 95% confidence
interval (95%CI) was also calculated.
In order to fit age-period-cohort (APC) models, the data
were grouped into periods of five years and synthetic overlapping
ten-year cohorts derived by subtracting the midpoint of the five-
year age group from the midpoint of the period. The APC
analyses were restricted to individuals dying of lung cancer
between the ages of 30 and 74.
The APC model provides a quantitative method of
estimating trends over time using objective criteria [13]. The
problem of identifiability, whereby the joint effects of age, period
and cohort cannot be estimated without further (often arbitrary)
assumptions or reparameterisations of the data makes the
implementation and interpretation of APC models problematical
[14-16]. In this study, the methods of Clayton and Schifflers are
used, thus a hierarchy of models that are fitted for each sex to
the rates:
{1} Age;
{2} Age + (Period or Cohort) Drift;
{3a} Age+ Drift + non-linear Period;
{3b} Age+ Drift + non-linear Cohort;
{4} Age + Drift + non-linear Period + non-linear Cohort.
The relative contribution of each effect to the model was
determined by comparing the change in the deviance and
degrees of freedom in two sequentially fitted models with the
appropriate chi-squared statistic. Hence, a comparison of model
{2} with {1} provides a test for drift (overall linear effect of
time, not attributable specifically to period or cohort) against the
model of no temporal trend (model {1}); a comparison of model
{3a} versus {2}, and model {3b} versus {2} tests for the effects
of non-linear period and non-linear cohort, respectively.
Comparing model {4} versus {3a} tests for the effects of non-
linear cohort effects, adjusting for drift and non-linear period.
Finally, the comparison of model {4} versus {3b} tests the
effects of non-linear period, adjusting for drift and non-linear
cohort.
The data on tobacco smoking in Poland were derived from
the several sources [17-21].
Results
There were 3,100 lung cancer deaths in men in Poland
and 692 in women in 1963. The number of deaths
increased rapidly in the following 30 years, and by 1999
the number of deaths reached 15,500 in males and 3,600
in females (Table I). The age-standardised mortality rates
in 1963 in men and women were 23.8/105 and 3.9/105,
respectively, whereas in 1999 the corresponding rates
were 67.3/105 and 11.5/105 (Table I).
J o i n p o i n t  r e g r e s s i o n  a n a l y s i s
Table II shows the time trends in lung cancer mortality in
men and women. In men, an analysis of time trends for all
age groups combined indicated a decrease in the overall
rate in the early 1990s, with the EAPC decelerating
throughout the study period. This observation held in all
age categories except the youngest (20-34), where there
were no changes in mortality. All estimated EAPCs (with
exception of one for the age 65-74) were statistically
significant at the p level of 0.05.
In women, increasing mortality trends were observed
in all time periods, but the rates of changes differed
between particular periods. An increase of the EAPCs
was seen in the youngest women (35-44) and also among
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umieralnoÊci z powodu raka p∏uca w Polsce musi pozostawaç dzia∏alnoÊç skierowana na obni˝enie cz´stoÊci palenia tytoniu
wÊród m´˝czyzn i kobiet, oraz zapobieganie rozpoczynania palenia wÊród dzieci i m∏odzie˝y.
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Table I. Lung cancer mortality in Poland, 1963-1999
Men Women
Year Number of deaths Crude rate Age-standardised rate Number of deaths Crude rate Age-standardised rate
1963 3 100 20,8 23,8 692 4,4 3,9
1964 3 574 23,6 26,7 740 4,6 4,1
1965 3 880 25,4 27,7 812 5,0 4,4
1966 4 294 27,9 30,0 857 5,3 4,5
1967 4 666 30,1 31,8 897 5,5 4,6
1968 5 131 32,7 34,2 1 010 6,1 5,1
1969 5 264 33,3 34,0 1 051 6,3 5,1
1970 5 623 35,6 36,1 1 019 6,1 4,8
1971 6 267 39,3 39,3 1 116 6,6 5,2
1972 6 428 40,0 39,8 1 143 6,7 5,1
1973 7 092 43,7 43,0 1 146 6,7 5,1
1974 7 402 45,0 43,6 1 269 7,3 5,4
1975 7 807 46,9 45,0 1 367 7,8 5,8
1976 8 408 50,3 48,2 1 354 7,7 5,7
1977 8 508 50,4 48,2 1 524 8,6 6,2
1978 9 106 53,4 51,0 1 558 8,7 6,3
1979 9 533 55,3 52,2 1 587 8,7 6,3
1980 10 146 58,5 55,1 1 812 9,9 7,2
1981 10 586 60,5 56,9 1 770 9,6 7,0
1982 10 726 60,8 57,3 1 912 10,3 7,3
1983 11 666 65,4 61,5 2 001 10,7 7,6
1984 12 229 67,9 63,5 2 162 11,4 8,1
1985 12 618 69,5 65,1 2 205 11,6 8,2
1986 12 932 70,8 66,3 2 310 12,0 8,4
1987 13 181 71,8 66,9 2 408 12,5 8,6
1988 13 791 74,7 69,3 2 539 13,1 9,3
1989 14 034 75,8 69,4 2 613 13,4 9,4
1990 14 539 78,3 71,1 2 805 14,4 9,9
1991 14 852 79,7 71,9 2 897 14,8 10,2
1992 14 688 78,6 70,3 2 852 14,5 10,0
1993 15 193 81,1 71,9 3 102 15,7 10,6
1994 15 250 81,3 71,3 3 181 16,1 10,7
1995 15 686 83,5 72,2 3 350 16,9 11,3
1996 15 478 82,4 70,3 3 411 17,2 11,3
1997* - - - - - -
1998* - - - - - -
1999 15 523 82,6 67,3 3 632 18,3 11,5
* no data available for the years 1997-1998 (Didkowska et al., 2002)
Table II. Changes in lung cancer mortality time trends, Poland, 1963-1999
Men
Age Number of joinpoints Year of joinpoint Period EAPC* 95%CI
All 3 1965-1972 5,2 4,5 5,8
1973 1973-1984 3,6 3,3 4,0
1985 1985-1990 1,7 0,5 2,9
1991 1991-1999 -0,6 -1,3 0,1
20-34 1 1965-1994 0,3 -0,7 1,3
1995 1995-1999 ***(a) *** ***
35-44 1 1965-1979 5,1 4,2 6,0
1980 1980-1999 -1,3 -2,0 -0,6
45-54 2 1965-1980 6,3 5,8 6,8
1981 1981-1989 1,2 -0,2 2,7
1990 1990-1999 -3,7 -5,0 -2,3
55-64 1 1965-1988 4,2 4,0 4,4
1989 1989-1999 -1,2 -1,9 -0,4
65-74 2 1965-1970 5,4 4,3 6,9
1971 1971-1992 2,6 2,4 2,8
1993 1993-1999 0,3 -1,1 1,6
75+ 2 1965-1972 7,6 5,9 9,4
1973 1973-1983 3,9 2,7 5,1
1984 1984-1999 1,5 0,7 2,2
45-54 year-olds. Large fluctuations of the EAPCs are
observed in women aged 55-64, 65-74 and 75+, although
some evidence of decelerating trends, clearly rates have
been steadily increasing trends since the 1970s.
A g e - p e r i o d - c o h o r t  a n a l y s i s
Table III shows the total deviance, degrees of freedom
and corresponding p-value for each hierarchical model
tested to assess the overall fit, while the differences in
the deviance and respective degrees of freedom in nested
models tested the significance of individual effects.
The full APC model was the best-fitting model for
both sexes, although for neither sex did the model
adequately fit the data, likely the effect of the variability
of the mortality count overdispersed relative to the
Poisson distribution. 
In males, the relative risk (RR) by birth cohort
increased up to the 1937 cohort. For the last two analysed
birth cohorts, 1942 and 1947, the RR dropped (Table IV,
Figure 1). In females, the RR was close to one until the
1937 cohort. For the last two observed cohorts the RR
increased although this rise was statistically significant
only for the last cohort) (Table IV, Figure 3).
Significant changes were also observed in risk for
subsequent periods of time. In men, the RR increased
until the period 1987-1991, but declined in the period
1992-1996 (Table V, Figure 2). In women, continuing
increases in the lung cancer risk were observed, and
the RR for the period 1992-1996 was 97% higher than
that of the reference period 1967-1971 (Table V, Figure 4).
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Women
Age Number of joinpoints Year of joinpoint Period EAPC* 95%CI
All 2 1965-1972 1,8 0,9 2,7
1973 1973-1989 3,8 3,5 4,1
1990 1990-1999 2,0 1,1 3,0
20-34 0 1965-1999 0,2 -1,0 1,4
35-44 1 1965-1977 0,6 -1,7 3,0
1978 1978-1999 4,5 3,2 5,8
45-54 1 1965-1973 1,3 -0,7 3,3
1974 1974-1999 4,4 4,0 4,9
55-64 3 1965-1968 8,0 3,1 13,2
1969 1969-1971 -6,1 -19,0 8,9
1972 1972-1979 7,8 5,7 10,0
1980 1980-1999 2,2 1,7 2,8
65-74 2 1965-1978 1,8 1,1 2,5
1979 1979-1992 3,9 3,1 4,7
1993 1993-1999 0,0 -2,8 2,9
75+ 1 1965-1985 3,7 3,4 4,1
1986 1986-1999 2,2 1,3 3,1
* – Estimated Annual Percentage Change
(a) not possible to make estimation
Table III. Age-period-cohort (APC), lung cancer, Poland, 1967-1996
Model Deviance DF p-value Diff dev Diff DF p-value (diff)
MEN
AGE 16120,1 45 0,000
AGE+DRIFT 2372,2 44 0,000 13747,9 1 0,000
AGE+COHORT (DRIFT) 1154,5 32 0,000 1217,7 12 0,000
AGE+PERIOD (DRIFT) 1318,1 40 0,000 1054,1 4 0,000
AGE+PEROD+COHORT 86,1 28 0,000
(a) Difference AP-APC 1232,0 12 0,000
(b) Difference AC-APC 1068,4 4 0,000
WOMEN
AGE 3749,0 45 0,000
AGE+DRIFT 218,8 44 0,000 3530,2 1 0,000
AGE+COHORT (DRIFT) 100,0 32 0,000 118,8 12 0,000
AGE+PERIOD (DRIFT) 191,1 40 0,000 27,7 4 0,000
AGE+PEROD+COHORT 69,9 28 0,000
(a) Difference AP-APC 121,2 12 0,000
(b) Difference AC-APC 30,1 4 0,000
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Figure 1. Relative risk for subsequent birth cohorts, lung, men, Poland
(reference category – 1922)
Figure 2. Relative risk by period of time, lung, men, Poland 
(reference category – 1967-1971)
Table IV. Lung cancer mortality relative risk estimates for subsequent
birth cohorts
Men Women
Cohort RR 95%CI RR 95%CI
1897 0,70 0,61 0,80 0,96 0,78 1,19
1902 0,77 0,70 0,86 1,01 0,85 1,19
1907 0,79 0,73 0,85 0,93 0,82 1,05
1912 0,80 0,76 0,84 0,88 0,81 0,96
1917 0,84 0,82 0,87 0,94 0,89 0,99
1922 1,00 (reference 1,00 (reference
category) category)
1927 1,17 1,13 1,20 1,04 0,99 1,09
1932 1,29 1,22 1,36 1,00 0,92 1,09
1937 1,36 1,26 1,47 1,01 0,89 1,14
1942 1,35 1,22 1,50 1,15 0,98 1,35
1947 1,25 1,09 1,42 1,38 1,13 1,69
Figure 3. Relative risk for subsequent birth cohorts, lung, women,
Poland (reference category – 1922)
Figure 4. Relative risk by period of time, lung, women, Poland
(reference category – 1967-1971)
Table V. Lung cancer mortality relative risk estimates for subsequent
time periods
Men Women
Period RR 95%CI RR 95%CI
1967-1971 1,00 (reference 1,00 (reference
category) category)
1972-1976 1,15 1,12 1,19 1,08 1,02 1,15
1977-1981 1,29 1,23 1,37 1,33 1,21 1,45
1982-1986 1,40 1,29 1,51 1,55 1,37 1,76
1987-1991 1,41 1,27 1,56 1,80 1,53 2,11
1992-1996 1,31 1,15 1,49 1,97 1,62 2,40
Figure 5. Lung cancer mortality, Poland, by age groups, men, observed
values (obs) and joinpoint regression (jpr)
C h a n g e s  i n  t o b a c c o  c o n s u m p t i o n  i n
Po l a n d
It has been reported by Didkowska et al. [20] that in 1923,
the consumption of tobacco in Poland was approximately
450 cigarettes per person per year. By 1938, estimated
annual consumption had risen moderately to 600
cigarettes per capita. Further increases in cigarette
consumption were observed in Poland after the Second
World War. In 1979 annual consumption was estimated at
2,740 cigarettes per person, and after a small decline in
the years 1979-1983 (average annual consumption of
2,300 cigarettes per person), consumption again started to
increase and reached 2500-2600 per capita by the end of
the 1980s (Figure 7) [20]. There was however, no sex-
specific information available.
The first survey on tobacco smoking prevalence in
the Polish population was carried out in 1974 [17]. Further
surveys took place in 1980 and 1982, and since 1985,
surveys on tobacco use have been carried out annually
(with the exception of 1989) [19]. Figures 8 to 12 illustrate
the changing patterns of tobacco smoking prevalence in
the Polish population.
In males, the highest overall prevalence of tobacco
smoking in Poland was observed in 1982 when about 62%
of the adult male population smoked (Figure 8) [19]. The
high smoking prevalence noted in that year was probably
caused by the introduction of coupons for cigarettes due
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Figure 6. Lung cancer mortality, Poland, by age groups, women,
observed values (obs) and joinpoint regression (jpr)
Source: data from Didkowska et al., 1996
Figure 7. Consumption of cigarettes in Poland, 1929-1996
Source: data from Przewozniak & Zatonski, 1996
Figure 8. The prevalence of tobacco smoking in Poland, 1974-1995,
by sex
Source: Data from Przewozniak & Zatonski, 1996
Figure 9. The prevalence of tobacco smoking in Poland, 1974-1995,
men, by age
Source: Data from Przewozniak & Zatonski, 1996
Figure 10. The prevalence of tobacco smoking in Poland, 1974-1995,
women, by age
to the shortage of cigarettes on the market during Martial
Law (1981-1983) [19]. Many ex-smokers returned to
smoking during that time. The prevalence in males
decreased to approximately 50% by the mid-1990s. The
analysis of smoking prevalence by age and cohort shows
that the overall decrease of tobacco smoking in men was
mainly due to decreases in older age groups and birth
cohorts. After 1985 the decrease was observed mainly in
men aged over 60 (although no further decrease was
observed in that age group after 1990) and among men
born in the 1920s and 1930s (Figures 9 and 11). No
significant changes in the prevalence of smoking were
observed in 20-59 year-olds of age from 1985 to1995, or in
men born between 1946 and 1965 (Figures 9 and 11).
As in men, the highest prevalence of tobacco
smoking in women also occurred in the early 1980s (30%
in 1982) (Figure 8). This dropped to approximately 25%
by the end of 1980s and remained at this level during the
first half of the 1990s. The analysis of changes in age
groups shows declines in smoking prevalence in the 1980s
and 1990s in the youngest age group (20-29 years) from
50% in 1980 to 20% in 1995. No changes were observed
in women aged 30-39 while in 40-49 year-olds smoking
prevalence rose (from 23% in 1980 to 40% in 1995)
(Figure 10). Smoking prevalence decreased for the birth
cohort born in 1936-1945, while in younger cohorts
smoking prevalence reached a plateau around 1990.
It has been reported by Mazur et al. [21] that 65% to
70% of 15 year-old Polish boys have smoked and about
30% smoke regularly. It is also worth emphasising that
among 15-year-old girls in Poland 16% were smokers in
1990 and this rose substantially to 28% in 1998 [21].
Discussion
This paper describes the changes in mortality from lung
cancer in Poland over last three decades, and analyses
these changes in the light of changes of the major lung
cancer risk factor, i.e. tobacco smoking. Trends in lung
cancer mortality and tobacco smoking in Poland and some
other Central and Eastern European countries up to 1990
were discussed previously by Kubik et al. [22]. The current
analysis serves as an update and a summary of the
influence of secular and generational influences on trends
in lung cancer mortality.
In general, the data analysed in this paper showed
a tendency towards a deceleration in the increase in the
rate of lung cancer mortality in the male population, and
in young and middle aged men, the first signs of
a decrease were observed in 1990s. In women the trends
are systematically rising, an observation particularly
evident in the young and middle aged women.
It has been reported previously that the quality of
cancer mortality statistics in Poland had reached
a satisfactory level, allowing descriptive epidemiological
analysis, from the beginning of the 1960s [23]. The data
are, generally, of reasonable quality and completeness
until 1996. Then, in 1997 and 1998 the completeness and
quality likely deteriorated due to problems in the Polish
health-care system, hence the data for these two years
were not adequate [4]. Since 1999, the situation seems
to have improved again [4].
Patterns of lung cancer occurrence are strongly
determined by exposure to tobacco smoking in the past. It
has been estimated by Parkin et al. [1] that at the
beginning of 1990s some 86% of lung cancer cases
worldwide in men was attributed to tobacco smoking,
with a corresponding proportion in women of approxi-
mately 50%. However, in European countries like Poland,
with a long history of tobacco smoking, more than 90% of
cases in men are tobacco-related [22, 24]. In women, the
proportion of tobacco-related lung cancer is much more
variable, which reflects differences in development of the
tobacco smoking epidemic in particular countries [1]. The
attributable proportion for Poland, carried out by Peto et
al. [24], was approximately 60%, and by Kubik et al. [22]
was 52%.
Despite significant changes in mortality from lung
cancer in Poland in recent decades, it nevertheless
remains the most frequent cancer in Polish men, and the
second most frequent cancer in women [4].
Our analysis showed deceleration in the increase of
overall cancer mortality rates in men. Analysis based on
the APC model indicates some plateau in mortality in
men since the end of 1980s and beginning of 1990s. It
remains in accordance with the results of the joinpoint
regression analysis, which indicates a non-statistically
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Source: Estimated based on the data from Przewozniak & Zatonski,
1996
Figure 11. The prevalence of tobacco smoking by birth cohorts, men,
Poland, 1975-1995
Source: Estimated based on the data from Przewozniak & Zatonski,
1996
Figure 12. The prevalence of tobacco smoking by birth cohorts,
women, Poland, 1975-1995
significant decrease (-0.6% per year in the period 1991-
1999). Our study confirms that the decrease in mortality
in men aged 20-44 years observed since the early 1980s
[22, 25], and restricted to men aged over 35. Such
a decrease in men aged 35-44 is somewhat surprising.
The first signs of a decrease in smoking prevalence in
Polish men were observed in the mid-1980s. Moreover,
the data from tobacco surveys indicated smoking
prevalence failed to decline amongst the younger age
groups (20-29 and 30-39) between 1974 and 1980.
Women born after 1940 experienced a significant
increase in lung cancer mortality risk. In the 1970s and
1980s these women were aged 35 to 54 years. These
findings are in accordance with the increasing smoking
prevalence in women born during the two decades after
the Second World War..
In addition to the increasing per capita tobacco
consumption in Poland until the end of the 1980s [20]
a decrease in smoking prevalence was also reported, from
1982 to 1990 in both men, and women [19], indicating
that smoking intensity increased, since a higher volume of
cigarettes was smoked by a decreasing proportion of
smokers. This observation is confirmed by data from
Przewozniak [18], where an increase in the average
number of cigarettes smoked per day in the period 1974-
1986 was reported (in males, from 13 cigarettes per day in
1974 to 19 in 1986, in females from 9 to 14, respectively).
It was also shown that average duration of exposure
increased in Poland during the 1980s, from 15 to 22 years
in men and from 8 to 15 years in women [18]. This
increase in the intensity and duration of exposure to
tobacco smoke in 1980s may affect trends in lung cancer
mortality in the current and next decade.
It is necessary to remember when analysing time
trends of lung cancer mortality or predicting the future
development that there are clear birth cohort effects, that
is, smoking amongst a given generation creates dele-
terious health effects in the same generation 2-3 decades
later [26, 27]. In men, those countries which first
experienced the smoking epidemic (e.g. U.K, Ireland,
and the U.S.) were also the first in which a decrease in
smoking prevalence occurred, with subsequent declines in
risk of lung cancer in the same generations [1].
Several initiatives were implemented in Poland in
the 1990s to decrease the prevalence of tobacco smoking
in men, and inhibit and subsequently reduce the
prevalence in women. In 1997 anti-tobacco legislation
was introduced, that included a ban on smoking in public
places, and a progressive ban on tobacco advertising. An
important feature of the legislation was the establishment
of a National Anti-Tobacco Programme embracing both
population-wide educational campaigns and advice to
help individual smokers quit. The first positive effects
are now being observed in the adult population: no
further increase of tobacco smoking prevalence has been
noted in the second half of the 1990s, and approximately
70% of current smokers declare their willingness to quit
[28].
However, the situation is much more difficult in
children and adolescents. It is intriguing that among 15
years old girls and boys the prevalence of smoking is
almost equal. It will probably be difficult to change the
situation in the near future. It was shown that in half of
the schools there was no formal ban of smoking – in only
26% of schools was a total ban in smoking implemented,
while in 71% smoking was allowed in selected places,
and in 2% of schools smoking was formally allowed [21].
In addition, young people react very differently to health
warning messages: adolescent smokers use cigarettes to
help express their self-image and identity, show solidarity
with their peers, and make them feel more grown-up and
sociable by association with a product that is dangerous
[29].
In view of the current lung cancer burden in the
Polish population, the level of tobacco smoking preva-
lence and per capita consumption, along with factors such
as effectiveness of prevention, and effectiveness of
screening for and treatment of lung cancer, it is likely
that mortality from lung cancer in Poland will continue to
rise in women in the next 20-30 years. Support for this
hypothesis comes from examination of: changes in the
smoking prevalence in last 10-15 years and in young birth
cohorts, increasing prevalence of smoking in young girls,
changes in the mortality time trends in the past, and
increasing risk of death from lung cancer in the youngest
generations of women. It is more difficult to predict
future changes in lung cancer mortality in Polish men.
Surveys of smoking prevalence carried out in the 1980s
and 1990s show no reduction in the prevalence in young
and middle-age men. Observations on smoking preva-
lence by birth generation also show stable levels of
smoking prevalence within younger birth cohorts. This
is somewhat inconsistent with mortality data however,
which indicate rates reached a plateau during the most
recent decade, corresponding with a similar observation in
the youngest birth cohorts.
There are several possible activities that may affect
lung cancer incidence and mortality in Poland in the
future. Some of them are currently being implemented.
The National Anti-Tobacco Programme includes a wide
dissemination of proven quitting strategies and involves
medical professionals and medical communities in the
cessation process. The current data on trends in smoking
prevalence amongst young people are not favourable. It is
of vital importance for the future health of the Polish
population to reduce smoking initiation among children
and adolescents by implementing effective school-based
tobacco-use prevention programmes [30]. It is, from
a long-term perspective, probably the most important
strategy for reducing the lung cancer burden in the
country. Other control measures, such as increasing
tobacco prices by an appropriate regulation of excise
taxes, banning tobacco advertising, or banning smoking in
public places may only be effective when they co-exist
with effective prevention programmes.
Other activities aimed at prevention and early
detection of lung cancer include screening trials, chemo-
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prevention trials (focused mainly on prevention of lung
cancer in high-risk groups), and studies on genetic
predisposition to smoking and nicotine addiction.
However, none of these activities have, as yet, proven
effective at a population level. Undoubtedly, the first
choice strategy to reduce mortality from lung cancer in
Poland should be the reduction of the prevalence of
smoking in men and women, and to target the rising
number of young tobacco smokers.
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